Kimberly-Clark is buying Tylenol maker Kenvue for nearly $50 billion, and Wall Street isn’t too fond of the deal. And for ...

A Mama Rosa’s Pizza opened up in Enterprise! They had their ribbon cutting ceremony to celebrate the official opening of the ...

Anna Paglia, State Street Investment Research CBO and chief business officer, joins CNBC's Dom Chu on the type of assets and ...

Failing the Chapter 7 means test doesn't end your pursuit of debt relief, but it may change the path you take.

Sam Altman said that shares of OpenAI were in demand, and that the company was making a "bet" and "taking a risk along with ...

The president's admission comes as he and his Republican allies continue to claim that President Joe Biden was unaware of his ...

Executive Decisions’ is a CNBC original podcast offering a rare window into the minds of top decision-makers. Hosted by Steve ...

Affiliated Managers Group, Inc. (AMG) (AMG) Q3 2025 Management View CEO Jay Horgen highlighted that AMG experienced a "landmark year" with record net inflows in alternative strategies and near record ...

On Monday, Kimberly-Clark, the company behind Kleenex, Huggies and Kotex, agreed to acquire Kenvue, the owner of Tylenol, Band-Aid and Neutrogena, in a cash and stock deal valued at approximately ...

Kimberly-Clark Corporation will acquire Kenvue Inc. in a nearly $50 billion merger, creating one of the world's largest ...

The players are seeking expansion to roster sizes whereas the current model of 11 or 12 players, depending on the salary cap, has led to the most injuries in recent memory. The WNBPA also aims to ...